Two Sigma Advisers
SLRN

Two Sigma Advisers’s ACELYRIN SLRN Stock Holding History

Two Sigma Advisers’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,100
Closed -$37.3K – 2525
2025
Q1 		$37.3K Sell
15,100
-1,600
-10% -$3.8K ﹤0.01% 2336
2024
Q4 		$52.4K Sell
16,700
-65,400
-80% -$317K ﹤0.01% 2278
2024
Q3 		$405K Sell
82,100
-118,300
-59% -$611K ﹤0.01% 1788
2024
Q2 		$884K Buy
+200,400
New +$939K ﹤0.01% 1611

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Advisers's SLRN Position: Q2 2025 in Review

Two Sigma Advisers sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 15,100 shares — an estimated $37.3K sold.

Two Sigma Advisers first reported a position in SLRN in Q2 2024 and held it in 4 quarters. The position peaked at $884K in Q2 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Two Sigma Advisers reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 15,100 ACELYRIN shares in Q2 2025, an estimated $37.3K.
  • Two Sigma Advisers first reported a position in ACELYRIN in Q2 2024 and held it in 4 quarters.
  • Two Sigma Advisers's ACELYRIN position peaked at $884K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.